A swarm of advertisements encouraging attention deficit hyperactivity disorder (ADHD) self-diagnosis and medication have appeared on TikTok in recent weeks, potentially violating the platform’s medical misinformation policy. TikTok seems to be prioritizing profit over the safety of its young user base by allowing companies to promote medication for a broad set of symptoms, such as being “chatty.”
A January NBC report exposed TikTok for allowing Cerebral, a health startup, to sponsor ADHD advertisements that promoted “negative body images and contained misleading health claims.”
According to NBC, the ads linked overeating and obesity to ADHD: “The ad said obesity is ‘five times more prevalent’ among adults with ADHD, and stated that getting treatment for the mental health disorder could help patients ‘stop overeating.’” The person featured in the advertisements was surrounded by junk food.
Although the report states that TikTok has since removed those specific advertisements, a Media Matters review found ads from Cerebral and other companies offering ADHD treatment that were similar to the ads TikTok took down. The ads seem to be capitalizing on the TikTok phenomenon of ADHD self-diagnosis, in which some creators oversimplify the disorder, leading viewers to try to decide themselves whether they have the disorder, sometimes incorrectly. This can push users to inappropriately seek ADHD medication, which can have dangerous side effects if used improperly. Self-diagnosis on TikTok is well-documented and can be dangerous.
Generalizing symptoms of ADHD may constitute medical misinformation, which TikTok prohibits. One advertisement by Cerebral encouraged female users who are “spacey, forgetful, or chatty” to pursue an ADHD diagnosis and medication.